Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$25,953,448
+$762,195 QoQ
Shares Held
102,191
-0.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#644
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEE DANNER & BASS INC holds $56,269,792 across 8 Drug Manufacturers - General names. JNJ ranks #1 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
102,191 | $25,953,448 | |
| 2 | MRK |
Merck & Co., Inc.
|
89,248 | $11,468,368 | |
| 3 | AMGN |
Amgen Inc
|
21,832 | $7,905,803 | |
| 4 | ABBV |
AbbVie Inc.
|
20,843 | $5,244,932 | |
| 5 | PFE |
Pfizer Inc
|
89,551 | $2,156,388 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,718 | $1,827,591 | |
| 7 | NVS |
Novartis AG
|
6,340 | $993,604 | |
| 8 | LLY |
ELI LILLY & Co
|
600 | $719,658 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,953,448 | 102,191 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $25,191,253 | 103,057 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $21,400,492 | 103,409 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $19,455,749 | 104,928 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $16,662,275 | 109,082 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $19,101,451 | 115,180 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $16,828,272 | 116,362 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $18,813,869 | 116,092 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $17,749,816 | 121,441 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $17,115,537 | 109,197 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $17,128,917 | 109,977 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $18,549,164 | 112,066 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $17,648,300 | 113,860 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $18,952,955 | 107,291 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $17,238,890 | 105,527 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $18,822,272 | 106,035 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $18,953,153 | 106,941 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $17,831,823 | 104,237 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $16,618,350 | 102,900 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $17,039,552 | 103,433 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $17,415,183 | 105,964 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $16,552,598 | 105,176 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $15,007,104 | 100,800 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $14,419,497 | 102,535 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $13,749,111 | 104,851 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||